DLBCL genes

Gene Tier DLBCL Reference Other references
ABI3BP 2 (Morin et al. 2013)
ACTB 1 (Lohr et al. 2012)
ACTG1 1 (Hübschmann et al. 2021)
ADAMTS1 2 (Hübschmann et al. 2021)
AICDA 2 (Arthur et al. 2018)
ANKRD12 2 (Hübschmann et al. 2021)
ANKRD17 2 (Reddy et al. 2017)
ARID1A 1 (Zhang et al. 2013) (Krysiak et al. 2017)
ARID1B 2 (Reddy et al. 2017)
ARID5B 2 (Reddy et al. 2017)
ATM 1 (Reddy et al. 2017)
ATR 2 (Reddy et al. 2017)
B2M 1 (Morin et al. 2011)
BCL10 1 (Morin et al. 2011) (Russler-Germain et al. 2023)
BCL11A 1
BCL2 1 (Tanaka et al. 1992) (Morin et al. 2011)
BCL6 1 (Morin et al. 2011)
BCL7A 1 (Arthur et al. 2018) (Krysiak et al. 2017)
BCOR 1
BCR 1
BIRC3 2 (Arthur et al. 2018)
BIRC6 1 (Reddy et al. 2017)
BLK 2
BRAF 1 (Tiacci et al. 2011)
BRINP3 2 (Reddy et al. 2017)
BTBD3 2 (Reddy et al. 2017)
BTG1 1 (Morin et al. 2011)
BTG2 1 (Morin et al. 2011)
BTK 1 (Albuquerque et al. 2017) (Krysiak et al. 2017)
CADPS2 2 (Hübschmann et al. 2021)
CARD11 1 (Lenz et al. 2008) (Morin et al. 2011)
CASP8 1 (Reddy et al. 2017)
CBLB 2 (Reddy et al. 2017)
CCL4 2 (Chapuy et al. 2018)
CCND3 1 (Morin et al. 2011)
CD22 2 (Reddy et al. 2017)
CD274 1 (Morin et al. 2011)
CD36 1 (Laura Pasqualucci, Trifonov, et al. 2011)
CD44 2 (Arthur et al. 2018)
CD58 1 (Morin et al. 2011)
CD70 1 (Morin et al. 2011) (Russler-Germain et al. 2023)
CD74 2 (Arthur et al. 2018)
CD79B 1 (Morin et al. 2011)
CD83 1 (Morin et al. 2013) (Russler-Germain et al. 2023)
CDC73 2 (Reddy et al. 2017)
CDH9 2 (Morin et al. 2013)
CDKN2A 1 (Morin et al. 2013)
CHD1 2 (Reddy et al. 2017)
CHD8 2 (Reddy et al. 2017)
CHST2 2 (Reddy et al. 2017)
CIITA 1 (Morin et al. 2011)
CNOT2 2 (Hübschmann et al. 2021)
CNTNAP5 2 (Morin et al. 2013)
COQ7 2 (Chapuy et al. 2018)
CREBBP 1 (Laura Pasqualucci, Dominguez-Sola, et al. 2011)
CRIP1 2 (Chapuy et al. 2018)
CXCR4 1 (Khodabakhshi et al. 2012) (Krysiak et al. 2017)
CXCR5 1 (Schmitz et al. 2018)
DAZAP1 1 (Pararajalingam et al. 2020)
DCAF6 2 (Reddy et al. 2017)
DDX10 2 (Reddy et al. 2017)
DDX3X 1 (Schmitz et al. 2018)
DHX16 2 (Hübschmann et al. 2021)
DICER1 2 (Reddy et al. 2017)
DNAH5 2 (Morin et al. 2013)
DNM2 2 (Hübschmann et al. 2021)
DNMT3A 2 (Reddy et al. 2017)
DOCK1 2 (Chapuy et al. 2018)
DSG4 2 (Morin et al. 2013)
DTX1 1 (Schmitz et al. 2018)
DUSP2 1 (Morin et al. 2013)
EBF1 1 (Bohle et al. 2013)
EEF1A1 1 (Hübschmann et al. 2021)
EIF2AK3 2
EP300 1 (Laura Pasqualucci, Dominguez-Sola, et al. 2011)
ETS1 1 (Morin et al. 2011)
ETV6 1 (Arthur et al. 2018)
EZH2 1 (Morin et al. 2010)
EZR 2
FAM102A 2
FAM38B 2 (Morin et al. 2013)
FANK1 2
FAS 1 (Scholl et al. 2007)
FAT4 2 (Morin et al. 2013)
FBXO11 1 (Hübschmann et al. 2021)
FBXW7 1 (Zhang et al. 2013)
FCRL3 2
FNBP1 2
FNDC1 2 (Morin et al. 2013)
FOXC1 1 (Schmitz et al. 2018)
FOXO1 1 (Morin et al. 2011)
FOXP1 2 (Reddy et al. 2017)
FUBP1 2 (Reddy et al. 2017)
FUT5 2 (Chapuy et al. 2018)
GABRA2 2 (Chapuy et al. 2018)
GAK 2 (Hübschmann et al. 2021)
GNA13 1 (Morin et al. 2011)
GNAI2 1 (Morin et al. 2013)
GNAS 2 (Reddy et al. 2017)
GOLGA5 2 (Reddy et al. 2017)
GPC5 2 (Schmitz et al. 2018)
GRB2 1 (Laura Pasqualucci, Trifonov, et al. 2011)
GRHPR 1 (Arthur et al. 2018)
GSG2 2 (Schmitz et al. 2018)
HDAC7 2 (Morin et al. 2013)
HIST1H1B 1 (Chapuy et al. 2018) (Krysiak et al. 2017)
HIST1H1C 1 (Morin et al. 2011)
HIST1H1D 1 (Morin et al. 2013) (Krysiak et al. 2017)
HIST1H1E 1 (Morin et al. 2013) (Krysiak et al. 2017)
HIST1H2AC 1 (Morin et al. 2013) (Krysiak et al. 2017)
HIST1H2AG 2 (Morin et al. 2013) (Krysiak et al. 2017)
HIST1H2AM 1 (Krysiak et al. 2017)
HIST1H2BC 1 (Reddy et al. 2017) (Krysiak et al. 2017)
HIST1H2BK 1
HIST1H3B 1 (Zhang et al. 2013)
HIST2H2BE 1 (Schmitz et al. 2018)
HLA-A 1
HLA-B 1
HLA-C 1
HLA-DMA 1
HLA-DMB 1
HLA-DQA1 1 (Hübschmann et al. 2021)
HNF1B 2 (Laura Pasqualucci, Trifonov, et al. 2011)
HNRNPD 1
HNRNPH1 1 (Pararajalingam et al. 2020)
HNRNPU 1 (Reddy et al. 2017)
HRAS 2 (Reddy et al. 2017)
HVCN1 1 (Krysiak et al. 2017)
ID3 2 (Schmitz et al. 2012)
IER2 2 (Morin et al. 2013)
IFNGR1 2 (Morin et al. 2013)
IGLL5 2 (Russler-Germain et al. 2023)
IKBKB 2 (Reddy et al. 2017)
IKBKE 2 (Hübschmann et al. 2021)
IKZF3 1 (Morin et al. 2013)
IL16 1
IL4R 1 (Duns et al. 2021)
IL6 2 (Chapuy et al. 2018)
INO80 2 (Zhang et al. 2013)
IRAG2 2
IRF1 2 (Hübschmann et al. 2021)
IRF4 1 (Morin et al. 2011)
IRF8 1 (Morin et al. 2011)
ITPKB 1 (Schmitz et al. 2018)
JAK1 2 (Zhang et al. 2013)
JAK3 2 (Zhang et al. 2013)
JUNB 1 (Reddy et al. 2017)
KCMF1 2 (Reddy et al. 2017)
KLF2 1 (Laura Pasqualucci, Trifonov, et al. 2011)
KLHL14 1 (Zhang et al. 2013)
KLHL21 2 (Schmitz et al. 2018)
KLHL6 1 (Morin et al. 2011)
KMT2C 1 (Zhang et al. 2013)
KMT2D 1 (Morin et al. 2011)
KRAS 1 (Lohr et al. 2012)
LAMA5 2 (Schmitz et al. 2018)
LAPTM5 2 (Hübschmann et al. 2021)
LCOR 1 (Arthur et al. 2018)
LIN54 2 (Reddy et al. 2017)
LPP 2 (Arthur et al. 2018)
LRP12 2 (Hübschmann et al. 2021)
LRRN3 2 (Morin et al. 2013)
LTB 1 (Chapuy et al. 2018)
LYN 1 (Chapuy et al. 2018)
MAGT1 2 (Reddy et al. 2017)
MALAT1 2 (Arthur et al. 2018)
MAP2K1 2 (Shin et al. 2015) (Louissaint et al. 2016)
MAP4K4 2 (Reddy et al. 2017)
MARK1 2 (Reddy et al. 2017)
MCL1 1 (Reddy et al. 2017)
MECOM 2 (Reddy et al. 2017)
MEF2B 1 (Morin et al. 2011)
MEF2C 1 (Arthur et al. 2018)
MET 2 (Reddy et al. 2017)
MGA 1 (Zhang et al. 2013)
MIR142 2 (Kwanhian et al. 2012)
MIR155HG 2
MPDZ 2 (Morin et al. 2013)
MPEG1 1 (Morin et al. 2013)
MS4A1 1 (Rushton et al. 2020)
MSH2 2 (Reddy et al. 2017)
MSH6 2 (Reddy et al. 2017)
MTOR 1 (Zhang et al. 2013)
MYB 2 (Reddy et al. 2017)
MYBPC2 2 (Schmitz et al. 2018)
MYC 1 (L. Pasqualucci et al. 2001)
MYD88 1 (Ngo et al. 2011)
MYO1E 2
MYOM2 1 (Laura Pasqualucci, Trifonov, et al. 2011)
N2RF2 2 (Hübschmann et al. 2021)
NANOG 2 (Chapuy et al. 2018)
NAV1 2 (Chapuy et al. 2018)
NCOA3 2
NCOR1 2 (Reddy et al. 2017)
NCOR2 1
NEAT1 2 (Arthur et al. 2018)
NF1 2 (Reddy et al. 2017)
NFKB1 1
NFKB2 2 (Reddy et al. 2017)
NFKBIA 1 (Lake et al. 2009) (Russler-Germain et al. 2023)
NFKBIE 1 (Morin et al. 2016)
NFKBIZ 1 (Morin et al. 2016)
NLRC5 1
NLRP5 2 (Morin et al. 2013)
NLRP8 2 (Chapuy et al. 2018)
NOL9 1 (Schmitz et al. 2018)
NOTCH1 1 (Laura Pasqualucci, Trifonov, et al. 2011)
NOTCH2 1 (Trøen et al. 2008)
ODZ3 2 (Morin et al. 2013)
OSBPL10 1 (Arthur et al. 2018)
P2RX5 2 (Morin et al. 2013)
P2RY8 1 (Lohr et al. 2012)
PAPOLG 2 (Schmitz et al. 2018)
PASK 2 (Morin et al. 2013)
PAX5 2 (L. Pasqualucci et al. 2001)
PCBP1 1
PCDHB11 2 (Morin et al. 2013)
PCLO 2 (Lohr et al. 2012)
PDE4DIP 2 (Chapuy et al. 2018)
PDS5B 2 (Morin et al. 2013) (Hübschmann et al. 2021)
PHF6 2 (Reddy et al. 2017)
PIK3CD 2 (Reddy et al. 2017)
PIK3R1 2 (Zhang et al. 2013)
PIM1 1 (L. Pasqualucci et al. 2001)
PIM2 1 (Arthur et al. 2018)
PKD1 2 (Morin et al. 2013)
PNPO 2 (Hübschmann et al. 2021)
POGZ 2 (Morin et al. 2013)
POU2AF1 1 (Krysiak et al. 2017)
POU2F2 1 (Zhang et al. 2013) (Krysiak et al. 2017)
PPP1R9B 2
PRDM1 1 (pasqualucciInactivationPRDM1BLIMP12006?)
PRKCB 2 (Morin et al. 2013)
PRKDC 1 (Schmitz et al. 2018) (Hübschmann et al. 2021)
PRPS1 2 (Chapuy et al. 2018)
PTEN 1
PTMA 2
PTPN1 2
PTPN23 2 (Morin et al. 2013)
PTPN6 2 (Reddy et al. 2017)
PTPRD 1
PTPRK 2 (Reddy et al. 2017)
RAC2 2 (Hübschmann et al. 2021)
RAD9A 2 (Chapuy et al. 2018)
RARA 2 (Reddy et al. 2017)
RB1 1 (Morin et al. 2013)
RCC 2
RFTN1 2 (Arthur et al. 2018)
RFX7 1
RFXAP 1
RHEX 2
RHOA 1 (L. Pasqualucci et al. 2001)
RHOH 2
RRAGC 1 (Okosun et al. 2016)
RUBCNL 2
RUNX1 2 (Reddy et al. 2017)
S1PR2 1 (Morin et al. 2011)
SAMD9L 2 (Morin et al. 2013)
SARM1 2 (Morin et al. 2013)
SEL1L3 2
SEPTIN9 2
SERPINA9 2 (Arthur et al. 2018)
SETD1B 1 (Reddy et al. 2017)
SETD2 2 (Zhang et al. 2013)
SETD5 2 (Reddy et al. 2017)
SF3B1 1
SGK1 1 (Morin et al. 2011)
SIAH2 2 (Hübschmann et al. 2021)
SIN3A 1
SLC34A2 2 (Hübschmann et al. 2021)
SMARCA4 1 (Zhang et al. 2013) (Krysiak et al. 2017)
SMEK1 2 (Chapuy et al. 2018)
SOCS1 1 (Morin et al. 2011)
SPEN 1 (Rossi et al. 2012)
SRRM2 2 (Morin et al. 2013) (Russler-Germain et al. 2023)
ST6GAL1 2 (Arthur et al. 2018)
STAT3 1 (Ohgami et al. 2014)
STAT5B 2 (Zhang et al. 2013)
STAT6 1 (Yildiz et al. 2015)
SYK 2 (Reddy et al. 2017)
SYPL1 2 (Morin et al. 2013)
TAF1 1 (Morin et al. 2013)
TAP1 2 (Schmitz et al. 2018)
TBC1D4 2 (Arthur et al. 2018)
TBL1XR1 1 (Mareschal et al. 2016)
TCL1A 2
TET2 1 (Albuquerque et al. 2017)
TGFBR2 2 (Reddy et al. 2017)
TIPARP 2 (Reddy et al. 2017)
TLR2 2 (Chapuy et al. 2018)
TMEM30A 1 (Morin et al. 2011)
TMSB4X 1 (Albuquerque et al. 2017)
TNFAIP3 1 (Compagno et al. 2009)
TNFRSF14 1 (Cheung et al. 2010)
TOX 1 (Reddy et al. 2017)
TP53 1 (Morin et al. 2011)
TRAF3 2 (Laura Pasqualucci, Trifonov, et al. 2011)
TRAF6 2 (Hübschmann et al. 2021)
TRIP12 1
TRRAP 1 (Parry et al. 2013)
UBE2A 1 (Reddy et al. 2017)
UBE2J1 2
UBR5 2 (Zhang et al. 2013)
UNC5B 2 (Hübschmann et al. 2021)
UNC5C 1
UNC5D 2
USP7 1
VPS13B 1
WAC 2 (Reddy et al. 2017)
WDFY3 2 (Morin et al. 2013)
WEE1 1 (Schmitz et al. 2018)
WNK1 2 (Hübschmann et al. 2021)
XBP1 2
XPO1 1 (Mareschal et al. 2016)
YY1 2 (Reddy et al. 2017)
ZBTB7A 2 (Reddy et al. 2017)
ZC3H12A 1 (Arthur et al. 2018)
ZCCHC7 2 (Arthur et al. 2018)
ZEB2 2 (Zhang et al. 2013)
ZFAT 2 (Reddy et al. 2017)
ZFP36L1 1 (Morin et al. 2011)
ZFX 2 (Reddy et al. 2017)
ZNF217 2 (Hübschmann et al. 2021)
ZNF292 1 (Zhang et al. 2013)
ZNF423 2 (Chapuy et al. 2018)
ZNF608 1 (Zhang et al. 2013) (Krysiak et al. 2017)

References

Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal, Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing Knowledge Discovery from Cancer Genomics Data with Galaxy.” GigaScience 6 (5): 1–13. https://doi.org/10.1093/gigascience/gix015.
Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide Discovery of Somatic Regulatory Variants in Diffuse Large B-cell Lymphoma.” Nature Communications 9 (1): 4001. https://doi.org/10.1038/s41467-018-06354-3.
Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of Early B-cell Factor 1 (EBF1) in Hodgkin Lymphoma.” Leukemia 27 (3): 671–79. https://doi.org/10.1038/leu.2012.280.
Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes.” Nature Medicine 24 (5): 679–90. https://doi.org/10.1038/s41591-018-0016-8.
Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. 2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis.” Cancer Research 70 (22): 9166–74. https://doi.org/10.1158/0008-5472.CAN-10-2460.
Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of Multiple Genes Cause Deregulation of NF-kappaB in Diffuse Large B-cell Lymphoma.” Nature 459 (7247): 717–21. https://doi.org/10.1038/nature07968.
Duns, Gerben, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021. “Characterization of DLBCL with a PMBL Gene Expression Signature.” Blood 138 (2): 136–48. https://doi.org/10.1182/blood.2020007683.
Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. 2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of Germinal Center Derived B-cell Lymphomas.” Leukemia 35 (7): 2002–16. https://doi.org/10.1038/s41375-021-01251-z.
Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J. Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in Lymphoma.” Oncotarget 3 (11): 1308–19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/.
Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. “Recurrent Somatic Mutations Affecting B-cell Receptor Signaling Pathway Genes in Follicular Lymphoma.” Blood 129 (4): 473–83. https://doi.org/10.1182/blood-2016-07-729954.
Kwanhian, Wiyada, Dido Lenze, Julia Alles, Natalie Motsch, Stephanie Barth, Celina Döll, Jochen Imig, et al. 2012. “MicroRNA-142 Is Mutated in about 20% of Diffuse Large B-cell Lymphoma.” Cancer Medicine 1 (2): 141–55. https://doi.org/10.1002/cam4.29.
Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical Hodgkin Lymphoma but Are Not a Unifying Feature of Non-EBV-associated Cases.” International Journal of Cancer 125 (6): 1334–42. https://doi.org/10.1002/ijc.24502.
Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma.” Science 319 (5870): 1676–79.
Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair, Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012. “Discovery and Prioritization of Somatic Mutations in Diffuse Large B-cell Lymphoma (DLBCL) by Whole-Exome Sequencing.” Proceedings of the National Academy of Sciences of the United States of America 109 (10): 3879–84. https://doi.org/10.1073/pnas.1121343109.
Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. “Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct Lymphoma with Frequent MAPK Pathway Mutations.” Blood 128 (8): 1093–1100. https://doi.org/10.1182/blood-2015-12-682591.
Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients Expands the Repertoire of Somatic Mutations in Diffuse Large B-cell Lymphoma.” Genes, Chromosomes & Cancer 55 (3): 251–67. https://doi.org/10.1002/gcc.22328.
Morin, Ryan D., Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, Rebecca L. Johnston, Lauren Chong, Jasleen Grewal, et al. 2016. “Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 22 (9): 2290–300. https://doi.org/10.1158/1078-0432.CCR-15-2123.
Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. “Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal-Center Origin.” Nature Genetics 42 (2): 181–85. https://doi.org/10.1038/ng.518.
Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. “Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” Nature 476 (7360): 298–303. https://doi.org/10.1038/nature10351.
Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and Structural Analysis of Diffuse Large B-cell Lymphoma Using Whole-Genome Sequencing.” Blood 122 (7): 1256–65. https://doi.org/10.1182/blood-2013-02-483727.
Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active MYD88 Mutations in Human Lymphoma.” Nature 470 (7332): 115–19. https://doi.org/10.1038/nature09671.
Ohgami, Robert S., Lisa Ma, Ahmad Monabati, James L. Zehnder, and Daniel A. Arber. 2014. “STAT3 Mutations Are Present in Aggressive B-cell Lymphomas Including a Subset of Diffuse Large B-cell Lymphomas with CD30 Expression.” Haematologica 99 (7): e105–107. https://doi.org/10.3324/haematol.2013.101543.
Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. “Recurrent mTORC1-activating RRAGC Mutations in Follicular Lymphoma.” Nature Genetics 48 (2): 183–88. https://doi.org/10.1038/ng.3473.
Pararajalingam, Prasath, Krysta M. Coyle, Sarah E. Arthur, Nicole Thomas, Miguel Alcaide, Barbara Meissner, Merrill Boyle, et al. 2020. “Coding and Noncoding Drivers of Mantle Cell Lymphoma Identified Through Exome and Genome Sequencing.” Blood 136 (5): 572–84. https://doi.org/10.1182/blood.2019002385.
Parry, Marina, Matthew J. J. Rose-Zerilli, Jane Gibson, Sarah Ennis, Renata Walewska, Jade Forster, Helen Parker, et al. 2013. “Whole Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients with Splenic Marginal Zone Lymphoma.” PloS One 8 (12): e83244. https://doi.org/10.1371/journal.pone.0083244.
Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. “Inactivating Mutations of Acetyltransferase Genes in B-cell Lymphoma.” Nature 471 (7337): 189–95. https://doi.org/10.1038/nature09730.
Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of the Coding Genome of Diffuse Large B-cell Lymphoma.” Nature Genetics 43 (9): 830–37. https://doi.org/10.1038/ng.892.
Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of Multiple Proto-Oncogenes in B-cell Diffuse Large-Cell Lymphomas.” Nature 412 (6844): 341–46. https://doi.org/10.1038/35085588.
Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.” Cell 171 (2): 481–494.e15.
Rossi, Davide, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin, Silvia Rasi, Valeria Spina, Sara Monti, et al. 2012. “The Coding Genome of Splenic Marginal Zone Lymphoma: Activation of NOTCH2 and Other Pathways Regulating Marginal Zone Development.” The Journal of Experimental Medicine 209 (9): 1537–51. https://doi.org/10.1084/jem.20120904.
Rushton, Christopher K., Sarah E. Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, et al. 2020. “Genetic and Evolutionary Patterns of Treatment Resistance in Relapsed B-cell Lymphoma.” Blood Advances 4 (13): 2886–98. https://doi.org/10.1182/bloodadvances.2020001696.
Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. 2023. “Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis: Alliance A151303.” Blood Advances 7: 5524–39. https://doi.org/10.1182/bloodadvances.2023010779.
Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson, James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018. “Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” The New England Journal of Medicine 378 (15): 1396–1407. https://doi.org/10.1056/NEJMoa1801445.
Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics.” Nature 490 (7418): 116–20. https://doi.org/10.1038/nature11378.
Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector, and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of FAS/CD95 Gene in Nodal Diffuse Large B-cell Lymphoma.” Leukemia & Lymphoma 48 (5): 957–63. https://doi.org/10.1080/10428190701230858.
Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases.” Annals of Laboratory Medicine 35 (2): 257–59. https://doi.org/10.3343/alm.2015.35.2.257.
Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of Non-Hodgkin’s Lymphomas.” Blood 79 (1): 229–37.
Tiacci, Enrico, Vladimir Trifonov, Gianluca Schiavoni, Antony Holmes, Wolfgang Kern, Maria Paola Martelli, Alessandra Pucciarini, et al. 2011. “BRAF Mutations in Hairy-Cell Leukemia.” The New England Journal of Medicine 364 (24): 2305–15. https://doi.org/10.1056/NEJMoa1014209.
Trøen, Gunhild, Iwona Wlodarska, Abdirashid Warsame, Silvia Hernández Llodrà, Christiane De Wolf-Peeters, and Jan Delabie. 2008. “NOTCH2 Mutations in Marginal Zone Lymphoma.” Haematologica 93 (7): 1107–9. https://doi.org/10.3324/haematol.11635.
Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 Mutations in Follicular Lymphoma.” Blood 125 (4): 668–79. https://doi.org/10.1182/blood-2014-06-582650.
Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. “Genetic Heterogeneity of Diffuse Large B-cell Lymphoma.” January.

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.